Candriam SCA’s Pliant Therapeutics PLRX Stock Holding History

Candriam SCA’s Portfolio PLRX Stock Details PLRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$11.9M	Buy
2024 Q3	$9.34M	Hold
2024 Q2	$8.96M	Buy
2024 Q1	$8.17M	Buy
2023 Q4	$8.2M	Buy
2023 Q3	$5.46M	Buy
2023 Q2	$4.8M	Buy
2023 Q1	$5.88M	Buy